Gold, Silver Focus ...
Health Care: Drugs
Forest Laboratories Inc. (FRX: NYSE)
$37.76 -0.22 | -0.58%
05/21/13 - 11:21 AM ET
Company Balance Sheet
| Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | n.a. | 1.58B | 2.14B | 1.86B |
| Receivables | n.a. | 471.78M | 535.49M | 475.65M |
| Inventories | n.a. | 298.12M | 451.36M | 467.77M |
| Other Current Assets | n.a. | 142.77M | 204.25M | 76.96M |
| Total Current Assets | n.a. | 3.59B | 5.26B | 4.58B |
| Property, Plant & Equipment, Gross | n.a. | 701.16M | 636.19M | 602.78M |
| Accumulated Depreciation & Depletion | n.a. | 341.14M | 316.42M | 279.50M |
| Property, Plant & Equipment, Net | n.a. | 360.02M | 319.77M | 323.28M |
| Intangibles | 0.00 | 2.10B | 725.49M | 466.74M |
| Other Non-Current Assets | 0.00 | 728.40M | 531.22M | 742.86M |
| Total Non-Current Assets | 0.00 | 3.91B | 1.66B | 1.64B |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 0.00 | 7.49B | 6.92B | 6.22B |
| Accounts Payable | n.a. | 162.57M | 190.77M | 130.20M |
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Liabilities | n.a. | 0.00 | 0.00 | 0.00 |
| Total Current Liabilities | n.a. | 929.31M | 937.86M | 979.65M |
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Income Taxes | n.a. | 860.41M | 485.72M | 353.98M |
| Other Non-Current Liabilities | n.a. | 25.22M | 0.00 | 0.00 |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 0.00 | 885.63M | 485.72M | 353.98M |
| Total Liabilities | 0.00 | 1.81B | 1.42B | 1.33B |
| Preferred Stock Equity | n.a. | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | 0.00 | 5.68B | 5.50B | 4.89B |
| Common Par | n.a. | 42.88M | 42.50M | 42.41M |
| Additional Paid In Capital | 0.00 | 1.70B | 1.63B | 1.57B |
| Cumulative Translation Adjustment | n.a. | 0.00 | 0.00 | 0.00 |
| Retained Earnings | 0.00 | 9.09B | 8.11B | 7.06B |
| Treasury Stock | n.a. | -5.15B | -4.29B | -3.78B |
| Other Equity Adjustments | n.a. | -2.93M | 8.00M | 3.70M |
| Total Capitalization | n.a. | 5.68B | 5.50B | 4.89B |
| Total Equity | 0.00 | 5.68B | 5.50B | 4.89B |
| Total Liabilities & Stock Equity | 0.00 | 7.49B | 6.92B | 6.22B |
| Total Common Shares Outstanding | 266.28M | 265.62M | 286.12M | 302.39M |
| Preferred Shares | n.a. | 0.00 | 0.00 | 0.00 |
| Treasury Shares | n.a. | 163.12M | 138.86M | 121.70M |
| Basic Weighted Shares Outstanding | 266.81M | 273.56M | 291.06M | 303.39M |
| Diluted Weighted Shares Outstanding | 266.81M | 274.02M | 291.18M | 303.78M |
| Number of Employees | NA | 5700 | 5600 | 5200 |
| Number of Part-Time Employees | NA | 0 | 0 | 0 |
Portfolios with FRX
- Portfolio NameUser Type
- ProCarl Icahn
- UserMike Fatah's Companies with...
- ContributorStocks With Big Insider Buy...
- ContributorPharmaceutical Short Squeez...
- ContributorEarnings Short Squeeze Play...
- UserSm. Magic July 5 13
- UserLong Term Stock Picks
- UserRikedom
- Userjohnnystocks
- ProRichard Pzena - Pzena Inves...
Latest FRX Headlines from TheStreet
- July Options Now Available For Forest Laboratories (FRX) 05.20.13 | 01:05 pm
- Forest Reaches New 52-Week High (FRX) 05.14.13 | 11:05 am
- Analysts' Actions: MU BSX CVC FRX 05.10.13 | 08:05 am
- Ironwood's Constipation Drug Sales Disappoint 04.23.13 | 08:04 am
- Today's Drugs Industry Featured Laggard: Forest Laboratories Inc. (FRX) 04.16.13 | 05:04 pm
- Notable Two Hundred Day Moving Average Cross - FRX 04.16.13 | 04:04 pm
- 5 Stocks Pushing The Drugs Industry Downward 04.15.13 | 01:04 pm
- Forest Laboratories Becomes #183 Most Shorted S&P 500 Component, Replacing Allergan 04.10.13 | 03:04 pm
- Ziopharm Considers Options After Drug Failure 03.27.13 | 11:03 am
- Stock Futures Slide as Traders Eye Earnings 01.15.13 | 09:01 am
Press Releases for FRX
- From Perspectives To Struggles, Alzheimer's Family Caregivers Find Strength In Sharing - PR Newswire 02.05.13 | 10:02 am
- Forest Laboratories, Inc. Reports Fiscal Year 2013 Third Quarter Earnings - Business Wire 01.15.13 | 07:01 am
- Forest Laboratories, Inc. Announces Additional Settlement Agreement In BYSTOLIC® Patent Litigation - Business Wire 01.03.13 | 08:01 am
- Forest Laboratories, Inc. Sets Date And Conference Call For Fiscal 2013 Third Quarter Earnings - Business Wire 01.02.13 | 04:01 pm
- FACT SHEET -- Chronic Idiopathic Constipation - Business Wire 12.17.12 | 08:12 am
- Forest Laboratories And Almirall Announce Commercial Availability Of Tudorza™ Pressair™ In US Pharmacies - Business Wire 12.11.12 | 02:12 am
- Forest Laboratories, Inc. To Present Cariprazine Results From A Phase 3 Trial And Two Pharmacology Studies At The American College Of Neuropsychopharmacology (ACNP) Annual Meeting - Business Wire 12.03.12 | 05:12 pm
- Forest Laboratories, Inc. Announces Additional Settlement Agreements In BYSTOLIC® Patent Litigation - Business Wire 11.28.12 | 04:11 pm
- Forest Laboratories Submits New Drug Application For Cariprazine For The Treatment Of Both Schizophrenia And Manic Or Mixed Episodes Associated With Bipolar I Disorder - Business Wire 11.28.12 | 02:11 am
- Forest Laboratories And Adamas Pharmaceuticals Enter Into Licensing Agreement For The Development And Commercialization Of A Fixed Dosed Combination Of Namenda XR® And Donepezil For Alzheimer’s Disease - Business Wire 11.14.12 | 08:11 am
Partner Headlines for FRX
- Cree, Seagate, Sandisk: Why Richie Freeman Likes Them - Investor's Business Daily 04.02.13 | 06:04 pm
- Barron's Recap (3/23/13): World's Best CEOs - Benzinga 03.24.13 | 01:03 pm
- NIRI Appoints Charles Triano to Board of Directors - Benzinga 03.20.13 | 09:03 am
- UPDATE: Credit Suisse Raises PT to $44 on Forest Laboratories on Positive Linzess Survey - Benzinga 03.15.13 | 01:03 pm
- EU Approval for Ironwood's Constella - Analyst Blog - Zacks 11.30.12 | 02:11 pm
- 3 Undervalued Healthcare Stocks Being Sold By Hedge Funds - Seeking Alpha 11.29.12 | 09:11 am
- Data on Pfizer's Lyrica - Analyst Blog - Zacks 11.19.12 | 07:11 pm
- For NovaBay, Simplicity Is The Father Of Invention - Seeking Alpha 11.12.12 | 09:11 am
- Earnings Scorecard: Forest Labs - Analyst Blog - Zacks 10.26.12 | 06:10 pm
- Pre-Market Earnings Report for October 16, 2012 : JNJ, KO, UNH, GS, PNC, STT, GWW, OMC, MAT, FRX, CBSH, DPZ - NASDAQ 10.15.12 | 08:10 pm
